CLINICAL_TRIALS
trial_result
· 2025-07-03
Clinical Trial Update: A Study to Assess the Pharmacodynamics of Lemborexant in Korean Participants With Insomnia Disorder [Phase 2]
Summary
Phase 2 pharmacodynamics study of lemborexant in Korean participants with insomnia disorder has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Co., Ltd. | Conditions: Sleep Initiation and Maintenance Disorders | Phase 2 | Status: COMPLETED | Results posted: 2025-07-03